22q11.2 Deletion Syndrome Clinical Trial
Official title:
Study of Arithmetic Abilities of Children With 22q11.2 Deletion Syndrome Aged From 4 to 11 Years Old
The study ARITH22 will investigate the role of visuo-spatial attention on arithmetic abilities of children with 22q11.2 deletion syndrome.
Children with 22q11.2 deletion syndrome often have arithmetic learning disability because of magnitude representation impairment. Previous works suggested that magnitude representation impairment could be a result of endogenous visuo-spatial attention dysfunction in 22q11.2DS. Nevertheless this relationship is still poor explored. The influence of visuo-spatial abilities on arithmetic achievement could also be modulated by developmental age. The study ARITH22 will test these hypotheses thanks to magnitude comparisons tasks, in children with 22q11.2 deletion syndrome and matched children without developmental disease. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04639960 -
Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome
|
N/A | |
Completed |
NCT01781923 -
Cognitive Remediation in 22q11DS
|
N/A | |
Terminated |
NCT03284060 -
Social Cognition Training and Cognitive Remediation
|
N/A | |
Completed |
NCT02895906 -
Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
|
Phase 1 | |
Recruiting |
NCT04639388 -
Understanding of Psychotic Disorders in Children With 22q11.2DS
|
N/A | |
Completed |
NCT00916955 -
Genetic Modifiers for 22q11.2 Syndrome
|
||
Recruiting |
NCT05924347 -
Early Scoliotic Changes in Children at Increased Risk for Scoliosis Development
|
||
Recruiting |
NCT00556530 -
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
|
||
Completed |
NCT02460328 -
Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome
|
N/A | |
Completed |
NCT04647500 -
Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome
|
N/A |